Related Experiment Video
Updated: Jun 13, 2026

Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung
Published on: May 20, 2019
Diffuse alveolar hemorrhage
Abigail R Lara1, Marvin I Schwarz
1University of Colorado Health Sciences Center, Division of Pulmonary Sciences and Critical Care, 4200 E 9th Ave, Box C272, Denver, CO 80262, USA.
Abstract:
Diffuse alveolar hemorrhage (DAH) is often a catastrophic clinical syndrome causing respiratory failure. Recognition of DAH often requires BAL as symptoms are nonspecific, hemoptysis is absent in up to one-third of patients, and radiographic imaging is also nonspecific and similar to other acute alveolar filling processes. Once the diagnosis is established, the underlying cause must be established in order to initiate treatment. This review discusses the diagnosis of the underlying histologies and the clinical entities that are responsible for DAH as well as treatment options.
Related Concept Videos
Atelectasis II: Pathophysiology
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Hemorrhagic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Pulmonary Embolism I: Introduction
Pulmonary Edema II: Pathophysiology
